Dr. Arlene Siefker-Radtke, MD
Claim this profileStudies Urethral Cancer
Studies Solid Tumors
1 reported clinical trial
3 drugs studied
More about Arlene Siefker-Radtke, MD
Clinical Trial Related18 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Arlene Siefker-Radtke, MD has experience with
- Bortezomib
- Doxorubicin
- Gemcitabine
Breakdown of trials Arlene Siefker-Radtke, MD has run
Urethral Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Arlene Siefker-Radtke, MD specialize in?
Arlene Siefker-Radtke, MD focuses on Urethral Cancer and Solid Tumors. In particular, much of their work with Urethral Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Arlene Siefker-Radtke, MD currently recruiting for clinical trials?
No, Arlene Siefker-Radtke, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Arlene Siefker-Radtke, MD has studied deeply?
Yes, Arlene Siefker-Radtke, MD has studied treatments such as Bortezomib, Doxorubicin, Gemcitabine.
What is the best way to schedule an appointment with Arlene Siefker-Radtke, MD?
Apply for one of the trials that Arlene Siefker-Radtke, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.